MNKD
NASDAQ · Biotechnology
Mannkind Corp
$3.52
-0.03 (-0.85%)
Open$3.56
Previous Close$3.55
Day High$3.68
Day Low$3.40
52W High$6.51
52W Low$2.23
Volume—
Avg Volume8.13M
Market Cap1.13B
P/E Ratio168.85
EPS$0.02
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+798.0% upside
Current
$3.52
$3.52
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 344.18M | 226.77M | 248.98M |
| Net Income | 5.79M | 3.44M | -49,454,944 |
| Profit Margin | 1.7% | 1.6% | -19.9% |
| EBITDA | 48.82M | 30.56M | -82,218,351 |
| Free Cash Flow | — | — | -29,596,680 |
| Rev Growth | +51.8% | +51.8% | +22.2% |
| Debt/Equity | 1.64 | 1.64 | 1.00 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |